Goal directed fluid therapy in major hepatic resection surgeries, a prospective randomized study

fluid therapy in major hepatectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202012816670352

Enrollment

Registered

2020-12-25

Start date

2020-12-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Anaesthesia

Interventions

S group

C group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study population will include all patients scheduled for hepatic resection, Age range from 18- to 60-year, the following surgical categories will be included: ‘excision of lesion of liver’, ‘segmental resection of liver’, ‘lobectomy of liver’, ‘trisegmental resection of liver’, Right hepatectomy (segments V-VIII) or extended right hepatectomy (segments IV-VIII).

Exclusion criteria

Exclusion criteria: Exclusion criteria will include: lack of written consent, drug abuse, preoperative renal dysfunction, BMI >40, and coagulopathies.

Design outcomes

Primary

Measure	Time frame
hospital length of stay	—

Secondary

Measure	Time frame
the need for vasopressors	—

Countries

Egypt

Contacts

Public ContactAlrefaey Alrefaey

Mansoura university

refa3ey2@yahoo.com00201064203475

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026